Alexion To Pay $10M To Settle Patent Lawsuit

Law360, New York (February 19, 2008, 12:00 AM EST) -- Alexion Pharmaceuticals Inc. has agreed to pay $10 million to the Oklahoma Medical Research Foundation to settle a patent dispute related to the drug Soliris.

Under the settlement, Alexion will pay $10 million in order to acquire all rights and interests to the patents at issue, making payments over the remainder of 2008 and 2009. The ongoing litigation will be dismissed.

Alexion's Soliris drug was approved by the FDA to treat a rare blood disorder, paroxysmal nocturnal humoglobinuria, or PNH, which strikes one in a million...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.